tiprankstipranks
Amphastar Pharmaceuticals (DE:29A)
FRANKFURT:29A
Germany Market

Amphastar Pharmaceuticals (29A) Income Statement

Compare
0 Followers

Amphastar Pharmaceuticals Income Statement

Last quarter (Q4 2024), Amphastar Pharmaceuticals's total revenue was $186.98M, an increase of 4.98% from the same quarter last year. In Q4, Amphastar Pharmaceuticals's net income was $37.96M. See Amphastar Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 712.81M$ 644.39M$ 498.99M$ 437.77M$ 349.85M
Gross Profit
$ 373.86M$ 351.12M$ 248.86M$ 199.74M$ 143.34M
Operating Expenses
$ 168.44M$ 154.13M$ 141.36M$ 129.85M$ 132.39M
Depreciation and Amortization
$ 57.20M$ 41.78M$ 28.74M$ 26.75M$ 25.18M
EBITDA
$ 277.31M$ 240.29M$ 107.50M$ 111.78M$ 30.19M
Operating Income
$ 205.42M$ 196.99M$ 78.76M$ 43.13M$ -14.23M
Other Income/Expenses
$ -15.65M$ -25.63M$ 8.54M$ 14.25M$ -6.32M
Pretax Income
$ 189.76M$ 171.36M$ 116.04M$ 84.14M$ 4.64M
Net Income
$ 159.52M$ 137.54M$ 91.39M$ 62.12M$ 1.10M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 3.29$ 2.85$ 1.88$ 1.30$ 0.02
Diluted EPS
$ 3.06$ 2.60$ 1.74$ 1.25$ 0.02
Weighted Average Shares Outstanding
48.43M 48.27M 48.55M 47.78M 47.04M
Weighted Average Shares Outstanding (Diluted)
52.06M 53.00M 52.43M 49.78M 49.12M
Currency in USD

Amphastar Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis